InsiderTrades

Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-26 · accession 0001055726-24-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-28 2024-02-26 INO Weiner David B. Dir M - OptEx — +2,916 80.3K +4% —
DM 2024-02-28 2024-02-26 INO Weiner David B. Dir M - OptEx $0.00 -2,916 972 -75% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-26 M A 972 — 79,371 D — — (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
2 Common Common Stock 2024-02-26 M A 972 — 78,399 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units was as follows: 972 shares vested on February 26, 2022; 972 shares vested on February 26, 2023; and 972 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.
3 Common Common Stock 2024-02-26 M A 972 — 80,343 D — — (F4) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares will vest on February 26, 2025; and 972 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
4 Derivative Restricted Stock Unit 2024-02-26 M D 972 $0.00 0 D — · — to — 972 Common Stock (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units was as follows: 972 shares vested on February 26, 2022; 972 shares vested on February 26, 2023; and 972 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.
5 Derivative Restricted Stock Unit 2024-02-26 M D 972 $0.00 1,944 D — · — to — 972 Common Stock (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F4) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares will vest on February 26, 2025; and 972 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
6 Derivative Restricted Stock Unit 2024-02-26 M D 972 $0.00 972 D — · — to — 972 Common Stock (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.